P G Subramanian
Overview
Explore the profile of P G Subramanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maity A, Sathyanarayanan A, Kumar R, Vora J, Gawde J, Jain Dr H, et al.
Blood Adv
. 2024 Dec;
9(3):463-472.
PMID: 39622167
Acute promyelocytic leukemia (APL), distinguished by the presence of PML::RARA fusion transcript, is a medical emergency because of its high early death rate, which is preventable when diagnosed early. Current...
2.
Srinivasan S, Dhamne C, Patkar N, Chatterjee G, Roy Moulik N, Chichra A, et al.
Pediatr Blood Cancer
. 2023 Nov;
71(2):e30791.
PMID: 38014874
Background: Pediatric core binding factor acute myeloid leukemia (CBF-AML), although considered a favorable risk subtype, exhibits variable outcomes primarily driven by additional genetic abnormalities, such as KIT mutations. Procedure: In...
3.
Srinivasan S, Dhamne C, Roy Moulik N, Chichra A, Tembhare P, Patkar N, et al.
Indian J Pediatr
. 2023 Jun;
91(6):564-570.
PMID: 37380920
Objectives: Outcomes of childhood acute promyelocytic leukemia (APL) have exceeded 90% in the era of differentiating agents. In resource-limited settings, early mortality secondary to coagulopathy remains a significant challenge. Differentiation...
4.
Shetty D, Talker E, Dhamne C, Mohanty P, Chaubal K, Tembhare P, et al.
Pediatr Blood Cancer
. 2022 Apr;
69(10):e29658.
PMID: 35373889
No abstract available.
5.
Mirgh S, Gokarn A, Rajendra A, More A, Kamtalwar S, Katti K, et al.
Cancer Med
. 2021 Nov;
10(24):8777-8788.
PMID: 34786866
Background: There is paucity of data regarding clinical characteristics, laboratory parameters and outcomes of coronavirus disease (COVID-19) in cancer versus non-cancer patients, particularly from India. Materials And Methods: This was...
6.
Narasimhan M, Khamkar V, Tilwani S, Dalal S, Shetty D, Subramanian P, et al.
J Cell Commun Signal
. 2021 Oct;
16(2):207-222.
PMID: 34596797
Chronic myeloid leukemia (CML) epitomises successful targeted therapy, where inhibition of tyrosine kinase activity of oncoprotein Bcr-Abl1 by imatinib, induces remission in 86% patients in initial chronic phase (CP). However,...
7.
Jain H, Sengar M, Goli V, Thorat J, Tembhare P, Shetty D, et al.
Blood Adv
. 2021 Aug;
5(17):3436-3444.
PMID: 34461632
The expression of CD20 in precursor B-cell acute lymphoblastic leukemia (B-ALL) is associated with poor outcomes. The addition of rituximab to intensive chemotherapy in CD20+ ALL has led to improved...
8.
Nathany S, Chatterjee G, Ghai S, Roy Moulik N, Shetty D, Subramanian P, et al.
Int J Lab Hematol
. 2021 Aug;
43(6):1531-1538.
PMID: 34387930
Introduction: Juvenile myelomonocytic leukemia (JMML) is a rare childhood neoplasm (<5% cases), which has been categorized under myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the recent classification by the World Health Organization. Methods:...
9.
Shetty D, Jain H, Rohil Y, Khattry N, Sengar M, Bagal B, et al.
Indian J Med Res
. 2021 Aug;
153(4):475-483.
PMID: 34380794
Background & Objectives: B-cell chronic lymphocytic leukaemia (B-CLL) is one of the most common forms of adult leukaemia, with a highly variable clinical course. Specific chromosomal and genetic aberrations are...
10.
Jain H, Shetty D, Roy Moulik N, Narula G, Subramanian P, Banavali S
Cancer Genet
. 2021 Mar;
254-255:65-69.
PMID: 33647813
Intrachromosomal amplification of RUNX1 gene on chromosome 21 (iAMP21) is a rare occurrence in acute myeloid leukemia (AML). Herein, we describe a case of AML with amplification of RUNX1 and...